Summary
Neutropenia in Felty's Syndrome predisposes patients to recurrent bacterial infections. We have treated a patient for more than one year with G-CSF and ascertained that this growth factor can savely correct neutropenia over a long periode of time. G-CSF may constitute a new agent for the treatment and prophylaxis of infection in Felty's syndrome.
Similar content being viewed by others
References
Abdou NI (1983) Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome. Arthritis Rheum 26: 947–953
Hazenberg BPC, van Leeuwen M, van Rijswijk M (1989) Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis. Blood 74: 2769–2773
Joseph G, Neustadt DH, Hamm J, Kellihan M, Hadley T (1991) GM-CSF in the treatment of Felty syndrome. Am J Hematol 37: 55–56
Kaiser U, Klausmann M, Richter G, Pflüger K-H (1992) GM-CSF versus G-CSF in the treatment of infectious complication in Felty's syndrome — a cause report. Ann Hematol 64: 205–206
Markusse HM, Breedveld FC, Fibbe WE, Stern AC (1990) Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome. Arthritis Rheum 33: 1865–1867
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wandt, H., Seifert, M., Falge, C. et al. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor. Ann Hematol 66, 265–266 (1993). https://doi.org/10.1007/BF01738478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01738478